ArticleCancer biomarkers : section A of Disease markers
The impact of HER2 low positivity in hormone receptor-positive, HER2-negative breast cancer treated with neoadjuvant chemotherapy.
Mustafa ErsoyPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.